{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:38:05Z","timestamp":1759937885442},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,6]]},"DOI":"10.7759\/cureus.28855","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T20:24:56Z","timestamp":1662495896000},"source":"Crossref","is-referenced-by-count":2,"title":["A Case of New Delhi Metallo-\u03b2-Lactamases (NDM) Citrobacter sedlakii Osteomyelitis Successfully Treated With Ceftazidime-Avibactam and Aztreonam"],"prefix":"10.7759","author":[{"given":"Zachary A","family":"Rubnitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria N","family":"Kunkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vickie S","family":"Baselski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan A","family":"Summers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2020.08.002","article-title":"Multidrug-resistant bacteria in the community: an update","volume":"34","author":"van Duin D","year":"2020","unstructured":"van Duin D, Paterson DL. Multidrug-resistant bacteria in the community: an update. Infect Dis Clin North Am. 2020, 34:709-22. 10.1016\/j.idc.2020.08.002","journal-title":"Infect Dis Clin North Am"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-013-0640-7","article-title":"The ABCD's of \u03b2-lactamase nomenclature","volume":"19","author":"Bush K","year":"2013","unstructured":"Bush K. The ABCD's of \u03b2-lactamase nomenclature. J Infect Chemother. 2013, 19:549-59. 10.1007\/s10156-013-0640-7","journal-title":"J Infect Chemother"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01944-19","article-title":"Validation of aztreonam-avibactam susceptibility testing using digitally dispensed custom panels","volume":"58","author":"Ransom E","year":"2020","unstructured":"Ransom E, Bhatnagar A, Patel JB, et al.. Validation of aztreonam-avibactam susceptibility testing using digitally dispensed custom panels. J Clin Microbiol. 2020, 58:10.1128\/JCM.01944-19","journal-title":"J Clin Microbiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2017.05.009","article-title":"Synergistic activity of ceftazidime-avibactam and aztreonam against serine and metallo-\u03b2-lactamase-producing gram-negative pathogens","volume":"88","author":"Wenzler E","year":"2017","unstructured":"Wenzler E, Deraedt MF, Harrington AT, Danizger LH. Synergistic activity of ceftazidime-avibactam and aztreonam against serine and metallo-\u03b2-lactamase-producing gram-negative pathogens. Diagn Microbiol Infect Dis. 2017, 88:352-4. 10.1016\/j.diagmicrobio.2017.05.009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.05.075","article-title":"In vitro activity of aztreonam-avibactam against metallo-\u03b2-lactamase-producing Enterobacteriaceae-A multicenter study in China","volume":"97","author":"Zhang B","year":"2020","unstructured":"Zhang B, Zhu Z, Jia W, et al.. In vitro activity of aztreonam-avibactam against metallo-\u03b2-lactamase-producing Enterobacteriaceae-A multicenter study in China. Int J Infect Dis. 2020, 97:11-8. 10.1016\/j.ijid.2020.05.075","journal-title":"Int J Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00010-19","article-title":"Aztreonam plus clavulanate, tazobactam, or avibactam for treatment of infections caused by metallo-\u03b2-lactamase-producing gram-negative bacteria","volume":"63","author":"Emeraud C","year":"2019","unstructured":"Emeraud C, Escaut L, Boucly A, Fortineau N, Bonnin RA, Naas T, Dortet L. Aztreonam plus clavulanate, tazobactam, or avibactam for treatment of infections caused by metallo-\u03b2-lactamase-producing gram-negative bacteria. Antimicrob Agents Chemother. 2019, 63:10.1128\/AAC.00010-19","journal-title":"Antimicrob Agents Chemother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00472-17","article-title":"In vitro activity of aztreonam-avibactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated by clinical laboratories in 40 countries from 2012 to 2015","volume":"61","author":"Karlowsky JA","year":"2017","unstructured":"Karlowsky JA, Kazmierczak KM, de Jonge BL, Hackel MA, Sahm DF, Bradford PA. In vitro activity of aztreonam-avibactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated by clinical laboratories in 40 countries from 2012 to 2015. Antimicrob Agents Chemother. 2017, 61:10.1128\/AAC.00472-17","journal-title":"Antimicrob Agents Chemother"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa504","article-title":"Aztreonam\/avibactam activity against clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019","volume":"76","author":"Sader HS","year":"2021","unstructured":"Sader HS, Carvalhaes CG, Arends SJ, Castanheira M, Mendes RE. Aztreonam\/avibactam activity against clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019. J Antimicrob Chemother. 2021, 76:659-66. 10.1093\/jac\/dkaa504","journal-title":"J Antimicrob Chemother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02243-16","article-title":"Can ceftazidime-avibactam and aztreonam overcome \u03b2-lactam resistance conferred by metallo-\u03b2-lactamases in Enterobacteriaceae?","volume":"61","author":"Marshall S","year":"2017","unstructured":"Marshall S, Hujer AM, Rojas LJ, et al.. Can ceftazidime-avibactam and aztreonam overcome \u03b2-lactam resistance conferred by metallo-\u03b2-lactamases in Enterobacteriaceae?. Antimicrob Agents Chemother. 2017, 61:10.1128\/AAC.02243-16","journal-title":"Antimicrob Agents Chemother"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13510","article-title":"Treatment of invasive IMP-4 Enterobacter cloacae infection in transplant recipients using ceftazidime\/avibactam with aztreonam: a case series and literature review","volume":"23","author":"Cairns KA","year":"2021","unstructured":"Cairns KA, Hall V, Martin GE, et al.. Treatment of invasive IMP-4 Enterobacter cloacae infection in transplant recipients using ceftazidime\/avibactam with aztreonam: a case series and literature review. Transpl Infect Dis. 2021, 23:e13510. 10.1111\/tid.13510","journal-title":"Transpl Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-225440","article-title":"Two for the price of one: emerging carbapenemases in a returning traveller to New York City","volume":"2018","author":"Mittal J","year":"2018","unstructured":"Mittal J, Szymczak WA, Guo Y, et al.. Two for the price of one: emerging carbapenemases in a returning traveller to New York City. BMJ Case Rep. 2018, 2018:10.1136\/bcr-2018-225440","journal-title":"BMJ Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01008-17","article-title":"Ceftazidime-avibactam and aztreonam, an interesting strategy to overcome \u03b2-lactam resistance conferred by metallo-\u03b2-lactamases in Enterobacteriaceae and Pseudomonas aeruginosa","volume":"61","author":"Davido B","year":"2017","unstructured":"Davido B, Fellous L, Lawrence C, Maxime V, Rottman M, Dinh A. Ceftazidime-avibactam and aztreonam, an interesting strategy to overcome \u03b2-lactam resistance conferred by metallo-\u03b2-lactamases in Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2017, 61:10.1128\/AAC.01008-17","journal-title":"Antimicrob Agents Chemother"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa586","article-title":"Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by metallo-\u03b2-lactamase-producing Enterobacterales","volume":"72","author":"Falcone M","year":"2021","unstructured":"Falcone M, Daikos GL, Tiseo G, et al.. Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by metallo-\u03b2-lactamase-producing Enterobacterales. Clin Infect Dis. 2021, 72:1871-8. 10.1093\/cid\/ciaa586","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/apm.12687","article-title":"Orthopaedic biofilm infections","volume":"125","author":"Zimmerli W","year":"2017","unstructured":"Zimmerli W, Sendi P. Orthopaedic biofilm infections. APMIS. 2017, 125:353-64. 10.1111\/apm.12687","journal-title":"APMIS"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/110770-a-case-of-new-delhi-metallo--lactamases-ndm-citrobacter-sedlakii-osteomyelitis-successfully-treated-with-ceftazidime-avibactam-and-aztreonam","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:40:13Z","timestamp":1707507613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/110770-a-case-of-new-delhi-metallo--lactamases-ndm-citrobacter-sedlakii-osteomyelitis-successfully-treated-with-ceftazidime-avibactam-and-aztreonam"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.28855","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,6]]}}}